A new bone repair scaffold combined with chitosan/ hydroxyapatite and sustained releasing icariin

来源 :Chinese Science Bulletin | 被引量 : 0次 | 上传用户:GAODAOQUAN
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Icariin, a plant-derived flavonol glycoside, has been proved as an osteoinductive agent for bone tissue engineering. A new bone repair scaffold was generated by thorough mixing of icariin and chitosan/ hydroxyapatite (icariin-CS/HA) using freeze-drying technigue. Characteristics of morphology, mechanical properties, biocompatibility, drug release behavior and bone repair abilities in vivo were evaluated. The results show that drug loading process of icariin did not affect physical structure of CS/HA composite significantly but decreased mechanical properies of CS/HA composite, which happened with a high dosage; icariin-CS/HA had favorable cell compatibility and promoted osteogenic differentiation of hBMSCs; the controlled release of icariin was satisfactory and the release retained after 90 d in vitro. In addition, icariin-CS/HA scaffolds had favorable osteoconduction and osteoinduction in vivo, and could fill bone defect sites and stimulate newborn bone tissues formation at early stage. On the basis of these data, icariin-CS/HA is believed to be an optical bone repair scaffold for tissue engineering. Icariin, a plant-derived flavonol glycoside, has been proved as an osteoinductive agent for bone tissue engineering. A new bone repair scaffold was generated by empty mixing of icariin and chitosan/ hydroxyapatite (icariin-CS/HA) using freeze-drying technigue. Characteristics of morphology, mechanical properties, biocompatibility, drug release behavior and bone repair abilities in vivo were evaluated. The results show that drug loading process of icariin did not affect physical structure of CS/HA composite significantly but declined mechanical properies of CS/HA composite. ,其发生其一次与高生; icariin-CS/HA had optimal cell compatibility and promoted osteogenic differentiation of hBMSCs; the controlled release of icariin was satisfactory and the released retained after 90 d in vitro. In addition, icariin-CS/HA scaffolds Had advantageous osteoconduction and osteoinduction in vivo, and could fill bone defect sites and growth newborn bone tissues formation at early stag e. On the basis of these data, icariin-CS/HA is believed to be an optical bone repair scaffold for tissue engineering.
其他文献
〔答〕氨苄青霉素(以下简称氨苄)是一种广谱新型青霉素,对革兰氏阳性菌和大部分革兰氏阴性菌都有较好抗菌效果,临床应用日益广泛,随之却又出现配合欠妥问题。经临床实践、文
苯妥英钠长期以来主要用于癫痫的治疗,近年来国内报道有一些新用途。本文扼要介绍苯妥英钠治疗枕大神经痛及慢性支气管炎的疗效。 Phenytoin sodium has long been mainly u
A Fe-Ni soft magnetic film was prepared in sulphate solution by electroplating. The influences of the molar ratio of n[Fe2+]/n[Ni2+], current density, bath temp
2006年《中国摄影家》杂志与上海迪派数码科技发展有限公司合作推出重磅器材专拦“迪派评测”。在每期栏目中,将以第一时间重点介绍新款摄影器材的详细性能、评测报告,以其专
本文介绍制剂中扑热息痛的K_2Cr_2O_7氧化—分光测定法,操作简易快速,结果准确,适合常规分析使用。在6M硫酸中于80℃经15分钟,扑热息痛与K_2Cr_2O_7能产生定量的氧化还原反
11月24日至28日,由洛阳市文联、衡阳市文广新局主办,洛阳美术馆、衡阳美术馆承办的洛阳·衡阳书画名家作品邀请展在洛阳美术馆举行,本次联展对促进两市的文化艺术交流与观摩,
自1966年Chambon等人发现聚(ADP—核糖)以来,对该多聚体的多种生物学作用尤其是与DNA修复关系的研究日趋深入,现已发展成为一个新的领域。(ADP-核糖)转移酶(ADPRT)抑制剂的
血小板功能异常和动脉血栓性栓塞、冠心病、心肌梗塞及高血压病等关系密切。血小板具有粘附、聚集及释放反应功能,血小板聚集抑制剂的临床应用有其特殊实用价值。 Abnormal
同一药物,虽然剂型、剂量相同,但不同厂家生产的产品,其溶出速度和生物利用度可能不同,此已由许多药品所证实(例如泼尼松、甲基磺丁脲、地高辛等).若溶出速度与生物利用度有
近年来,国内外均有报道胰酶片(肠溶衣)对大多数病例是无效的。为此,作者对口服胰酶肠溶衣片进行了体内、外崩解试验研究。体外试验:经测定肠溶衣片在人工胃液、人工肠液(按